CN114621200B - Near-infrared fluorescent probe and preparation method and application thereof - Google Patents
Near-infrared fluorescent probe and preparation method and application thereof Download PDFInfo
- Publication number
- CN114621200B CN114621200B CN202210255409.2A CN202210255409A CN114621200B CN 114621200 B CN114621200 B CN 114621200B CN 202210255409 A CN202210255409 A CN 202210255409A CN 114621200 B CN114621200 B CN 114621200B
- Authority
- CN
- China
- Prior art keywords
- diethylamino
- fluorescent probe
- perchlorate
- methylene
- carboxyphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007850 fluorescent dye Substances 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title abstract description 15
- -1 2- ((acetoxy methoxyl) carbonyl) phenyl Chemical group 0.000 claims abstract description 38
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 claims abstract description 34
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 claims abstract description 33
- 239000000523 sample Substances 0.000 claims abstract description 32
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 claims abstract description 31
- ITMCEJHCFYSIIV-UHFFFAOYSA-M triflate Chemical compound [O-]S(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-M 0.000 claims abstract description 16
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 claims abstract description 14
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims abstract description 8
- YDCHPLOFQATIDS-UHFFFAOYSA-N methyl 2-bromoacetate Chemical compound COC(=O)CBr YDCHPLOFQATIDS-UHFFFAOYSA-N 0.000 claims abstract description 7
- OIRDBPQYVWXNSJ-UHFFFAOYSA-N methyl trifluoromethansulfonate Chemical compound COS(=O)(=O)C(F)(F)F OIRDBPQYVWXNSJ-UHFFFAOYSA-N 0.000 claims abstract description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 33
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 claims description 16
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 15
- 150000001875 compounds Chemical class 0.000 claims description 13
- 239000007787 solid Substances 0.000 claims description 13
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 6
- RYGIHSLRMNXWCN-UHFFFAOYSA-N quinoline-3-carbaldehyde Chemical compound C1=CC=CC2=CC(C=O)=CN=C21 RYGIHSLRMNXWCN-UHFFFAOYSA-N 0.000 claims description 6
- 238000000967 suction filtration Methods 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 238000004440 column chromatography Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 239000011541 reaction mixture Substances 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 3
- 229910019142 PO4 Inorganic materials 0.000 claims description 3
- 229910052786 argon Inorganic materials 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 239000010452 phosphate Substances 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 239000003153 chemical reaction reagent Substances 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 150000003384 small molecules Chemical class 0.000 abstract description 6
- 239000003068 molecular probe Substances 0.000 abstract description 4
- 230000007547 defect Effects 0.000 abstract description 2
- 238000005457 optimization Methods 0.000 abstract description 2
- 150000002894 organic compounds Chemical class 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract 3
- 239000007795 chemical reaction product Substances 0.000 abstract 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 18
- 229940125904 compound 1 Drugs 0.000 description 11
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
- 239000008103 glucose Substances 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000005481 NMR spectroscopy Methods 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 206010008342 Cervix carcinoma Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 3
- 201000010881 cervical cancer Diseases 0.000 description 3
- 229940125782 compound 2 Drugs 0.000 description 3
- 229940126214 compound 3 Drugs 0.000 description 3
- 238000000799 fluorescence microscopy Methods 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 238000011503 in vivo imaging Methods 0.000 description 3
- 201000007270 liver cancer Diseases 0.000 description 3
- 208000014018 liver neoplasm Diseases 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000001917 fluorescence detection Methods 0.000 description 2
- 230000034659 glycolysis Effects 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 238000010859 live-cell imaging Methods 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- KYNSBQPICQTCGU-UHFFFAOYSA-N Benzopyrane Chemical compound C1=CC=C2C=CCOC2=C1 KYNSBQPICQTCGU-UHFFFAOYSA-N 0.000 description 1
- 108091006149 Electron carriers Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6456—Spatial resolved fluorescence measurements; Imaging
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1088—Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Optics & Photonics (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
The invention belongs to the technical field of organic compounds and preparation thereof, and discloses a near-infrared fluorescent probe and a preparation method and application thereof, aiming at the defects of the existing small-molecule fluorescent probe for detecting NAD (P) H. The fluorescent probe is 3- (9- (2- ((acetoxy methoxyl) carbonyl) phenyl) -6- (diethylamino) -2, 3-dihydroxy methylene-4 (1H) -methylene) -1-methyl quinoline-1-perchlorate trifluoromethanesulfonate. Firstly, 4-diethylamino keto acid reacts with cyclohexanone, concentrated sulfuric acid and perchloric acid; then reacting the reaction product with 3-quinoline formaldehyde; further reacting the obtained reaction product with methyl trifluoromethanesulfonate; and finally reacting with methyl bromoacetate to generate the fluorescent probe. The probe has the advantages of simple synthetic route, easily obtained raw materials and lower cost. The probe can respond to NAD (P) H, has high selectivity to NAD (P) H, has an emission wavelength of about 745nm, and can lay a foundation for the structure optimization of a subsequent molecular probe.
Description
Technical Field
The invention belongs to the technical field of organic compounds and preparation thereof, and particularly relates to a near-infrared fluorescent probe and a preparation method and application thereof.
Background
1, 4-dihydronicotinamide adenine dinucleotide (NADH) and its phosphate ester (NADPH) are coenzymes necessary for maintaining the redox homeostasis of the cell. They are used as an electron carrier, are closely related to oxidoreductase, and participate in important redox reactions in metabolic pathways such as glycolysis, citric acid cycle and beta-oxidation. NAD (P) H is an important product of energy metabolism, and is closely related to the occurrence of cancer. Therefore, finding a suitable method to achieve detection of NAD (P) H levels is crucial.
Currently, many methods for in vitro detection of NAD (P) H have been developed, such as electrophoresis, enzymatic methods, and fluorescence imaging methods, such as gene-encoded proteins, nanoparticles, small molecule probes, and the like. Among them, small molecule fluorescent probes are widely concerned because of their many advantages, such as simple preparation, convenient use, good cell permeability, low toxicity, and suitability for in vivo experiments. However, most probes are off-type fluorescent probes and cannot be applied to live cell imaging, even in vivo imaging. Therefore, it is of great importance to develop an open-type fluorescent probe that can be used for live cell imaging as well as in vivo imaging.
Disclosure of Invention
Aiming at the defects of the existing small molecular fluorescent probe for detecting NAD (P) H, the invention provides a near-infrared fluorescent probe and a preparation method and application thereof. The fluorescent probe is a small molecular probe based on benzopyran phosphonium salt framework, which is found in previous researches by the inventor of the application and can respond to NAD (P) H. Therefore, the design and synthesis of the fluorescent probe of the compound are completed through a series of organic synthesis reactions, ultraviolet absorption and fluorescence tests are carried out on the fluorescent probe, and then NAD (P) H can be detected in cell confocal and in vivo experiments.
In order to achieve the purpose, the invention adopts the following technical scheme:
the invention provides a near-infrared fluorescent probe, which is 3- (9- (2- ((acetoxy methoxyl) carbonyl) phenyl) -6- (diethylamino) -2, 3-dihydroxy methylene-4 (1H) -methylene) -1-methyl quinoline-1-perchlorate trifluoromethanesulfonate and has a structural formula as follows:
the invention also provides a preparation method of the near-infrared fluorescent probe, which comprises the following steps:
step 1, reacting 4-diethylamino keto acid with cyclohexanone, concentrated sulfuric acid and perchloric acid to generate 9- (2-carboxyphenyl) -6- (diethylamino) -1,2,3, 4-tetrahydroxy perchlorate;
step 3, reacting the 9- (2-carboxyphenyl) -6- (diethylamino) -4- (quinoline-3-methylene) -1,2,3, 4-tetrahydroxy perchlorate generated in the step 2 with methyl trifluoromethanesulfonate to generate 3- (9- (2-carboxyphenyl) -6- (diethylamino) -2, 3-dihydroxymethyl-4 (1H) -methylene) -1-methylquinoline-1-perchlorate trifluoromethanesulfonate;
and 4, reacting the 3- (9- (2-carboxyphenyl) -6- (diethylamino) -2, 3-dihydroxymethyl-4 (1H) -methylene) -1-methylquinoline-1-perchlorate trifluoromethanesulfonate generated in the step 3 with methyl bromoacetate to generate 3- (9- (2- ((acetoxymethoxy) carbonyl) phenyl) -6- (diethylamino) -2, 3-dihydroxymethylene-4 (1H) -methylene) -1-methylquinoline-1-perchlorate trifluoromethanesulfonate, and obtaining the near-infrared fluorescent probe.
Further, the preparation method specifically comprises the following steps:
step 1, adding cyclohexanone into concentrated sulfuric acid with the mass fraction of 98% dropwise at 0 ℃, stirring, then adding 4-diethylamino keto acid in batches, continuing stirring at 90-120 ℃, stopping the reaction after the reaction is carried out for 3-5 hours, pouring the final reaction mixture into water with the temperature of 0 ℃, adding 70% perchloric acid, carrying out suction filtration on the precipitated precipitate, and washing with water with the temperature of 0 ℃ to obtain an orange-red solid compound, namely 9- (2-carboxyphenyl) -6- (diethylamino) -1,2,3, 4-tetrahydroxy perchlorate;
and 3, adding methyl trifluoromethanesulfonate into dichloromethane, adding 9- (2-carboxyphenyl) -6- (diethylamino) -4- (quinoline-3-methylene) -1,2,3 and 4-tetrahydroxy perchlorate, stirring at room temperature for 3 hours, stopping reaction, cooling to separate out a purple solid, performing suction filtration, washing with dichloromethane, and drying to obtain a compound: 3- (9- (2-carboxyphenyl) -6- (diethylamino) -2, 3-dihydroxymethyl-4 (1H) -methylene) -1-methylquinoline-1-perchlorate trifluoromethanesulfonate;
step 4, adding 3- (9- (2-carboxyphenyl) -6- (diethylamino) -2, 3-dihydroxymethyl-4 (1H) -methylene) -1-methylquinoline-1-perchlorate trifluoromethanesulfonate and N, N-diisopropylethylamine to a reaction vessel, adding acetonitrile, mixing well, subsequently adding methyl bromoacetate to the mixed solution, stirring for 48H under argon protection, and separating by column chromatography to obtain the compound: and 3- (9- (2- ((acetoxymethoxy) carbonyl) phenyl) -6- (diethylamino) -2, 3-dihydroxymethylene-4 (1H) -methylene) -1-methylquinoline-1-perchlorate trifluoromethanesulfonate, namely obtaining the near-infrared fluorescent probe.
Further, in the step 1, cyclohexanone, 98% concentrated sulfuric acid by mass fraction, 4-diethylamino keto acid by mass fraction, and 70% perchloric acid by volume: volume: quality: volume =6.6mL:72mL:9.82g:7.9mL; the final reaction mixture was poured into 200mL of 0 ℃ water.
The mass of the 9- (2-carboxyphenyl) -6- (diethylamino) -1,2,3, 4-tetrahydroxy perchlorate, 3-quinolinecarboxaldehyde, piperidine and absolute ethyl alcohol in the step 2 is as follows: quality: volume: volume =2g:1g:0.04mL:35mL.
Volume of dichloromethane, methyl trifluoromethanesulfonate, 9- (2-carboxyphenyl) -6- (diethylamino) -4- (quinoline-3-methylene) -1,2,3, 4-tetrahydroxy perchlorate used in the step 3: volume: mass =108mL:1.2mL:1.53g.
The mass of the used amount of 3- (9- (2-carboxyphenyl) -6- (diethylamino) -2, 3-dihydroxymethyl-4 (1H) -methylene) -1-methylquinoline-1-perchlorate trifluoromethanesulfonate, N-diisopropylethylamine, acetonitrile and methyl bromoacetate in the step 4 is as follows: volume: volume: volume =60mg:0.124mL:2mL of: 0.1mL.
Further, the vacuum pump for suction filtration in step 1 and step 3, the mobile phase of the column chromatography in step 4 is dichloromethane: methanol = 8.
The invention also provides an application of the near-infrared fluorescent probe, which is used for preparing a reagent for detecting 1, 4-dihydronicotinamide adenine dinucleotide and phosphate ester thereof.
Compared with the prior art, the invention has the following advantages:
1. the invention provides an open type fluorescent probe which has higher signal-to-noise ratio.
2. The invention provides a small-molecule probe based on a benzopyran humate skeleton, which has the advantages of simple synthetic route, readily available raw materials and low cost.
3. The small molecular probe can respond to NAD (P) H, has high selectivity to NAD (P) H, has an emission wavelength of about 745nm, and can lay a foundation for the structure optimization of a subsequent molecular probe.
4. The invention provides biological application of a small molecule probe, and the long emission wavelength of the small molecule probe can be utilized in cell and mouse experiments, thereby being beneficial to the subsequent research of cancer.
Drawings
FIG. 1 is a hydrogen spectrum of nuclear magnetic resonance of a probe of the present invention;
FIG. 2 is a carbon spectrum of nuclear magnetic resonance of a probe of the invention;
FIG. 3 is a high resolution mass spectrum of a probe of the invention;
FIG. 4 is a spectral test chart of a probe of the present invention;
FIG. 5 is a graphic image of a cell image showing the detection of NAD (P) H by the probe of the present invention in different living cells;
FIG. 6 is a graph of an image of Hela cells with probes of the invention at different glucose concentrations;
FIG. 7 is a photograph of a mouse in vivo image of the probe of the present invention.
Detailed Description
The technical solution of the present invention will be specifically and specifically described below with reference to the embodiments of the present invention and the accompanying drawings. It should be noted that variations and modifications can be made by those skilled in the art without departing from the principle of the present invention, and these should also be construed as falling within the scope of the present invention.
Example 1
A near-infrared fluorescent probe is prepared by the following steps:
1) Preparation of Compound 2
A200 ml flask was charged with 98% by mass concentrated sulfuric acid (72 ml), and cyclohexanone (6.6 ml, 64mmol) was added dropwise to 98% concentrated sulfuric acid (72 ml) at 0 ℃ and stirred, and then 4-diethylaminoketoacid (9.82g, 32mmol) was added in portions, and the mixture was stirred at 90 ℃. The reaction was stopped after 3 hours. The final reaction mixture was poured into 0 ℃ water (200 ml), 70% by mass perchloric acid (7.9 ml) was added, and the precipitated precipitate was suction-filtered by a vacuum pump under reduced pressure and washed three times with 0 ℃ water to give compound 2 (15 g) as an orange-red solid, i.e., 9- (2-carboxyphenyl) -6- (diethylamino) -1,2,3, 4-tetrahydroxyperchlorate, in a yield of 98%.
2) Preparation of Compound 3
Compound 2 (2g, 4.2mmol), 3-quinolinecarboxaldehyde (1g, 6.3mmol) and piperidine (40. Mu.l) are added sequentially to a 50ml flask, and the compound is dissolved by addition of a certain amount of anhydrous ethanol (35 ml) as a solvent, and the final mixture is heated to 80 ℃ for reflux, reacted overnight, cooled to 0 ℃ for 2 hours after the reaction is completed and the temperature is returned to room temperature, to precipitate a purple solid, which is then washed 3 times with tert-butyl methyl ether to obtain compound 3 (1.5513 g) as 9- (2-carboxyphenyl) -6- (diethylamino) -4- (quinoline-3-methylene) -1,2,3, 4-tetrahydroxy perchlorate in 61% yield.
3) Preparation of Compound 4
Methyl trifluoromethanesulfonate (1200. Mu.l, 10.2 mmol) and compound 3 (1.53g, 2.5 mmol) were added to dichloromethane (108 ml), stirred at room temperature for 3 hours, the reaction was stopped, cooled to precipitate a purple solid, filtered with a vacuum pump, washed three times with dichloromethane, and dried to give compound 4 (0.9133 g), i.e., 3- (9- (2-carboxyphenyl) -6- (diethylamino) -2, 3-dihydroxymethyl-4 (1H) -methylene) -1-methylquinoline-1-perchlorate trifluoromethanesulfonate in 58% yield.
4) Preparation of Compound 1 (Probe)
Compound 4 (60mg, 0.097mmol) and N, N-diisopropylethylamine (124 μ l,0.75 mmol) were added to a 10ml round bottom flask and acetonitrile (2 ml) was added and mixed well, then methyl bromoacetate (100 μ l,1.02 mmol) was added to the mixed solution, stirred under argon for 48 hours and isolated by column chromatography (dichloromethane: methanol =8, vol.: 1) to give compound 1, i.e. 3- (9- (2- ((acetoxymethoxy) carbonyl) phenyl) -6- (diethylamino) -2, 3-dihydroxymethylene-4 (1H) -methylene) -1-methylquinoline-1-perchlorate triflate (near infrared fluorescence probe) in 22% yield.
FIG. 1 is a hydrogen spectrum of nuclear magnetic resonance of the probe of this example, which is shown in FIG. 1:
1 HNMR(600MHz,CDCl 3 )δ9.09(s,1H),8.96(s,1H),8.39(d,J＝6.7Hz,1H),8.28(d,J＝7.8Hz,1H),8.20(t,J＝7.0Hz,1H),8.07(s,1H),7.98(t,J＝7.1Hz,1H),7.84(t,J＝7.8Hz,1H),7.73(t,J＝7.6Hz,1H),7.28(s,2H),7.26(d,J＝7.4Hz,1H),7.10(d,J＝9.7Hz,1H),7.01(d,J＝9.6Hz,1H),5.77–5.73(m,2H),4.94(s,3H),4.29(s,4H),4.20–4.11(m,2H),3.84(s,2H),3.43(s,3H),3.37(s,2H),2.24(s,6H).
FIG. 2 is a carbon spectrum of NMR of the probe of this example, as shown in FIG. 2:
13CNMR(151MHz,CDCl 3 )δ169.3,167.9,163.6,161.6,158.8,156.4,152.3,137.2,136.5,134.5,134.1,133.8,132.7,131.8,130.6,130.6,130.3,129.8,129.7,129.7,129.1,129.0,127.8,123.7,118.8,118.7,118.0,98.2,86.7,80.0,62.5,54.2,53.4,42.4,29.6,14.0,12.1,10.5.
FIG. 3 is a high resolution mass spectrum of the probe of this example, which can be obtained from FIG. 3:
HRMS(ESI)[M] 2+ calculatedforC 38 H 38 N 2 O 5 :301.1390,found:301.1387。
example 2
The fluorescence probe prepared in example 1 was subjected to spectroscopic measurement:
the test was performed in system PBS: CH (CH) 3 CH 2 OH =3:2 (volume ratio), the concentration of the probe preparation mother liquor was 2mM, and the concentration of the NADH and NADPH mother liquors were 20mM. (all tests were carried out at 37 ℃ C. With temperature control)
The test results are shown in fig. 4. In FIG. 4 (a) is Compound 1 (10. Mu.M, PBS: CH) 3 CH 2 OH, volume ratio 3: 2) Change in uv absorption over time after addition of 100 μ MNADH; (b) Is compound 1 (10. Mu.M, PBS: CH) 3 CH 2 OH, volume ratio 3: 2) The fluorescence intensity of (D) varies with NADH concentration (0-100. Mu.M); (λ ex =680nm, slit: 10nm/10 nm); (c) Is compound 1 (10. Mu.M, PBS: CH) 3 CH 2 OH, volume ratio 3: 2) Changes in fluorescence spectra with increasing time after addition of 100 μm MNADH; (d) Is compound 1 (10. Mu.M) in PBS and CH 3 CH 2 Kinetic profile of addition of 100 μ MNADH to OH (volume ratio 3; (λ ex =680nm, slit: 10nm/10 nm); (e) Working curves of compound 1 (10. Mu.M) in the presence of different concentrations of NADH; (f) Is compound 1 (10. Mu.M, PBS: CH) 3 CH 2 OH, volume ratio 3: 2) Fluorescence intensity at 745nm after reacting with various ions, amino acids and enzymes in a 37 ℃ water bath for 2.5 hours; the abscissa a to w represent 200. Mu. MK, respectively + ，Na + ，Ca 2+ ，Mg 2+ ，F - ，Br - ，NO 2 - ，OH - ，HSO 3 - ，SO 3 2- ，SCN - ，H 2 O 2 VC, cys, hcy, GSH, lys, asn, lipase, pepsin, trypsin, NADPH, NADH.
As can be seen from FIG. 4, the ultraviolet absorption peak of the probe is at 556nm, plusAfter the probe enters NADH, a new absorption peak appears at 723nm, and the ultraviolet absorption at 556nm gradually decreases and the ultraviolet absorption at 723nm gradually increases (a) along with the increase of time, which indicates that the probe can respond to NADH. Subsequently, using 680nm as the excitation wavelength of the probe, when different concentrations of NADH (0-100. Mu.M) were added, a gradual increase in fluorescence intensity at 745nm was observed (b), indicating that the probe is concentration-dependent in response to NADH, and after the addition of 100. Mu. MNADH, the fluorescence intensity was also gradually increased over time (c and d), indicating that the probe is correspondingly time-dependent in response to a certain concentration of NADH. R of the curve in graph (e) 2 =0.99, indicating that the probe has a good linear relationship for detecting NADH. As can be seen from fig. (f): under the same condition, the fluorescence intensity for detecting NADPH and NADH is far higher than that of other substances, which shows that the fluorescent probe has good selectivity for NADPH and NADH. Meanwhile, the result of FIG. 4 also shows that the fluorescent probe of the present invention belongs to an open type fluorescent probe, and has a higher signal-to-noise ratio.
Example 3
Cell experiments: cell experiments were performed on the fluorescent probes prepared in example 1
(1) Confocal fluorescence detection of NAD (P) H in different living cells
FIG. 5 is a graphic image of cellular imaging of NAD (P) H detection in different living cells. Wherein: (a) As a result of imaging after incubating normal cells (7702), human cervical cancer cells (Hela), and human liver cancer cells (HepG 2) with 10. Mu.M of Compound 1 for 1 hour, respectively. (b) The average fluorescence intensity of three types of cells, namely normal cells (7702), human cervical cancer cells (Hela) and human liver cancer cells (HepG 2); normal cells (7702) were defined as 1.0 as a control group and data were expressed as mean ± SD (n = 3).
In the cell experiment (FIG. 5), it was found that when the probe was added to normal cells (7702), human cervical cancer cells (Hela), and human liver cancer cells (HepG 2), red fluorescence was generated, but the fluorescence intensity in the Hela and HepG2 cells was relatively higher than that in the normal cells (7702). It is demonstrated that compound 1 (the fluorescent probe of the present invention) can detect NAD (P) H levels in different cells, and that NAD (P) H levels in cancer cells are found to be higher than in normal cells.
(2) Confocal fluorescence detection of NAD (P) H in Hela cells at different glucose concentrations
FIG. 6 is an image of Hela cells at different glucose concentrations. (a) Imaging was performed after incubating Hela cells with 5, 10, 20mM glucose for 15 min, respectively, followed by 10 μ M compound 1 for 15 min; (b) The mean fluorescence intensity of Hela cells under different concentrations of glucose; the fluorescence intensity of the cells preincubated with 5mM glucose was defined as 1.0 as a control group, and the data were expressed as mean ± SD (n = 3).
As can be seen from fig. 6: when glucose was added at different concentrations to Hela cells having the highest average fluorescence intensity, the fluorescence intensity in Hela cells gradually increased as the glucose concentration increased. Indicating that NAD (P) H is produced during glycolysis of the cell.
From the above results it can be derived: the fluorescent probe can be used for the subsequent research of cancer.
Example 4
Mouse in vivo experiments: the probe at a mother liquor concentration of 2mM was diluted to 500. Mu.M, and 10. Mu.l was aspirated and injected into mice via tail vein. Fluorescence imaging in mice was performed after 0, 20, 30 and 50 minutes, respectively.
FIG. 7 is a photograph of in vivo fluorescence imaging of mice. It can be seen from the figure that: the fluorescence intensity in the mouse body gradually weakens from weak to strong along with the increase of time, which shows that the probe can detect NAD (P) H in the mouse body and can be used for in vivo imaging.
Claims (8)
1. A near-infrared fluorescent probe is characterized in that the probe is 3- (9- (2- ((acetoxy methoxyl) carbonyl) phenyl) -6- (diethylamino) -2, 3-dihydroxy methylene-4 (1H) -methylene) -1-methyl quinoline-1-perchlorate trifluoromethanesulfonate, and the structural formula of the near-infrared fluorescent probe is as follows:
2. the method for preparing the near-infrared fluorescent probe of claim 1, which is characterized by comprising the following steps:
step 1, adding cyclohexanone into concentrated sulfuric acid with the mass fraction of 98% dropwise at 0 ℃, stirring, then adding 4-diethylamino keto acid in batches, continuing stirring at 90-120 ℃, stopping the reaction after the reaction is carried out for 3-5 hours, pouring the final reaction mixture into water with the temperature of 0 ℃, adding 70% perchloric acid, carrying out suction filtration on the precipitated precipitate, and washing with water with the temperature of 0 ℃ to obtain an orange-red solid compound, namely 9- (2-carboxyphenyl) -6- (diethylamino) -1,2,3, 4-tetrahydroxy perchlorate;
step 2, adding 9- (2-carboxyphenyl) -6- (diethylamino) -1,2,3, 4-tetrahydroxy perchlorate, 3-quinolinecarboxaldehyde and piperidine into a reaction vessel in sequence, adding absolute ethyl alcohol to dissolve, heating the dissolved mixture to 80 ℃ to reflux, reacting overnight, cooling to 0 ℃ after the reaction is finished and the temperature is recovered to room temperature, standing for 2-4 h to precipitate purple solid, washing the solid with tert-butyl methyl ether, and drying the solid to obtain a compound: 9- (2-carboxyphenyl) -6- (diethylamino) -4- (quinolin-3-ylmethylene) -1,2,3, 4-tetrahydroxy perchlorate;
and 3, adding methyl trifluoromethanesulfonate into dichloromethane, adding 9- (2-carboxyphenyl) -6- (diethylamino) -4- (quinoline-3-methylene) -1,2,3 and 4-tetrahydroxy perchlorate, stirring at room temperature for 3 hours, stopping reaction, cooling to separate out a purple solid, performing suction filtration, washing with dichloromethane, and drying to obtain a compound: 3- (9- (2-carboxyphenyl) -6- (diethylamino) -2, 3-dihydroxymethyl-4 (1H) -methylene) -1-methylquinoline-1-perchlorate trifluoromethanesulfonate;
step 4, adding 3- (9- (2-carboxyphenyl) -6- (diethylamino) -2, 3-dihydroxymethyl-4 (1H) -methylene) -1-methylquinoline-1-perchlorate trifluoromethanesulfonate and N, N-diisopropylethylamine to a reaction vessel, adding acetonitrile, mixing well, subsequently adding methyl bromoacetate to the mixed solution, stirring for 48H under argon protection, and separating by column chromatography to obtain the compound: and 3- (9- (2- ((acetoxy methoxy) carbonyl) phenyl) -6- (diethylamino) -2, 3-dihydroxy methylene-4 (1H) -methylene) -1-methylquinoline-1-perchlorate trifluoromethanesulfonate to obtain the near-infrared fluorescent probe.
3. The method for preparing a near-infrared fluorescent probe according to claim 2, characterized in that: in the step 1, cyclohexanone, concentrated sulfuric acid with the mass fraction of 98%, 4-diethylamino keto acid with the mass fraction of 70% and the volume of the dosage of perchloric acid are as follows: volume: quality: volume =6.6mL:72mL of: 9.82g:7.9mL; the final reaction mixture was poured into 200mL of 0 ℃ water.
4. The method for preparing a near-infrared fluorescent probe according to claim 2, characterized in that: the mass of 9- (2-carboxyphenyl) -6- (diethylamino) -1,2,3, 4-tetrahydroxy perchlorate, 3-quinolinecarboxaldehyde, piperidine and absolute ethyl alcohol in the step 2 is as follows: quality: volume: volume =2g:1g:0.04mL:35mL.
5. The method for preparing a near-infrared fluorescent probe according to claim 2, characterized in that: the volume of the dichloromethane, the methyl trifluoromethanesulfonate and the 9- (2-carboxyphenyl) -6- (diethylamino) -4- (quinoline-3-methylene) -1,2,3, 4-tetrahydroxy perchlorate used in the step 3 is as follows: volume: mass =108mL:1.2mL:1.53g.
6. The method for preparing a near-infrared fluorescent probe according to claim 2, characterized in that: the mass of the used amount of 3- (9- (2-carboxyphenyl) -6- (diethylamino) -2, 3-dihydroxymethyl-4 (1H) -methylene) -1-methylquinoline-1-perchlorate trifluoromethanesulfonate, N-diisopropylethylamine, acetonitrile and methyl bromoacetate in the step 4 is as follows: volume: volume: volume =60mg:0.124mL:2mL of: 0.1mL.
7. The method for preparing a near-infrared fluorescent probe according to claim 2, characterized in that: the vacuum pump for suction filtration in the step 1 and the step 3, wherein the mobile phase of the column chromatography in the step 4 is dichloromethane: methanol = 8.
8. The near-infrared fluorescent probe of claim 1, which is used by: is used for preparing a reagent for detecting 1, 4-dihydronicotinamide adenine dinucleotide and phosphate thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210255409.2A CN114621200B (en) | 2022-03-15 | 2022-03-15 | Near-infrared fluorescent probe and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210255409.2A CN114621200B (en) | 2022-03-15 | 2022-03-15 | Near-infrared fluorescent probe and preparation method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN114621200A CN114621200A (en) | 2022-06-14 |
| CN114621200B true CN114621200B (en) | 2023-04-18 |
Family
ID=81901643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210255409.2A Active CN114621200B (en) | 2022-03-15 | 2022-03-15 | Near-infrared fluorescent probe and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114621200B (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110386898B (en) * | 2018-04-20 | 2022-07-29 | 南京大学 | Quinoline ring derivative fluorescent probe and preparation method and application thereof |
| CN110357865B (en) * | 2019-07-05 | 2022-09-23 | 东南大学 | Near-infrared fluorescent probe for detecting hNQO1 enzyme, and synthetic method and application thereof |
| CN112225743B (en) * | 2020-07-23 | 2021-10-08 | 嘉兴学院 | Quinolinyl near-infrared rhodamine fluorescent dye, ratiometric fluorescent probe, and synthesis and application thereof |
| CN112961177B (en) * | 2021-03-08 | 2022-04-19 | 中国药科大学 | Near-infrared fluorescent probe for detecting reduced nicotinamide adenine dinucleotide NADH and preparation method and application thereof |
-
2022
- 2022-03-15 CN CN202210255409.2A patent/CN114621200B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN114621200A (en) | 2022-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105924394B (en) | A kind of two-photon formaldehyde fluorescence probe and its preparation and application | |
| CN109053549B (en) | Two-photon fluorescent probe for positioning mitochondria to detect viscosity and synthetic method and application thereof | |
| CN110498758B (en) | Near-infrared fluorescent probe for identifying glutathione and preparation and application thereof | |
| CN110423487B (en) | Rhodol derivative dye and application thereof | |
| CN109651835A (en) | A kind of IR780 keto-acid Molecule of Cyanine Dyes and preparation method thereof and crystal structure | |
| CN112778288B (en) | Near-infrared solid-state light-emitting fluorescent probe and preparation method and application thereof | |
| CN113354627B (en) | Near-infrared fluorescent compound for detecting viscosity and preparation and application thereof | |
| CN111233804A (en) | Benzopyranoylium ion-coumarin derivative and synthetic method and application thereof | |
| CN114621200B (en) | Near-infrared fluorescent probe and preparation method and application thereof | |
| CN111793371B (en) | 3, 5-asymmetrically modified BODIPY near-infrared fluorescent dye and preparation method thereof | |
| CN110642857B (en) | Difunctional fluorescent probe for detecting viscosity and pH, and preparation and application thereof | |
| CN114163463A (en) | Near-infrared fluorescent two-photon fluorescent probe design aiming at real-time change of hydrogen peroxide in tumor process and synthetic method thereof | |
| CN110357896B (en) | Compound, preparation and application thereof in detecting divalent copper ions and strong acid pH | |
| CN114634497B (en) | Cysteine/homocysteine response AIE fluorescent probe and preparation method and application thereof | |
| CN117263858A (en) | Double-quinoline NADH fluorescent probe and preparation method thereof | |
| CN115181118B (en) | Novel curcumin fluorescent probe and preparation method and application thereof | |
| CN112920157B (en) | Benzene coupling benzopyran derivative and synthesis method and application thereof | |
| CN110669350B (en) | Piperidyl BODIPY red-light fluorescent dye and preparation method and application thereof | |
| CN111635385B (en) | Mitochondrion-targeted two-photon excitation near-infrared emission hydrogen sulfide fluorescent probe and preparation method and application thereof | |
| CN113354612A (en) | Peruvian red-based RNA near-infrared fluorescent probe for mitochondria and nucleolus, preparation and application | |
| CN115894427B (en) | Near-infrared frequency up-conversion fluorescent probe, preparation method thereof and application thereof in detection of biological mercaptan | |
| CN118290413B (en) | Near infrared fluorescent probe for human serum albumin detection and preparation method and application thereof | |
| CN112079860B (en) | Fluorodipyrrole fluorescent probe, preparation method and application thereof in viscosity detection | |
| CN116041301B (en) | Organic small molecular probe for detecting amino acid and preparation method and application thereof | |
| CN117088835B (en) | Luminous probe and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |